The importance of the interaction between hepatocyte and hepatic stellate cells in fibrogenesis induced by fatty accumulation

Experimental and Molecular Pathology

Volumn 98, Issue 1, 2015, Pages 85-92

  Giraudi, Pablo J ^a   Barbero Becerra, Varenka J ^a,b   Marin, Veronica ^a   Chavez Tapia, Norberto C ^a,b   Tiribelli, Claudio ^a,c   Rosso, Natalia ^a  

^a Centro Studi Fegato   (Italy)

^b Liver Research Unit Médica Sur Clinic and oFoundation   (Mexico)

^c UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Extracellular matrix turnover; Fibrogenesis; Hepatic stellate cells; Hepatocytes; Steatosis

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; FATTY ACID; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; COLLAGEN; GELATINASE A; MESSENGER RNA; MMP2 PROTEIN, HUMAN; TIMP2 PROTEIN, HUMAN;

ARTICLE; CELL ACTIVATION; CELL CONTACT; CELL INTERACTION; CELLS BY BODY ANATOMY; COCULTURE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FATTY LIVER; FIBROGENESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID STORAGE; LIVER CELL; LIVER FIBROSIS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STELLATE CELL; CELL CULTURE; CHEMICALLY INDUCED; DRUG EFFECTS; ENZYME IMMUNOASSAY; GENETICS; LIVER; LIVER CIRRHOSIS; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELLS, CULTURED; COCULTURE TECHNIQUES; COLLAGEN; EXTRACELLULAR MATRIX; FATTY ACIDS, NONESTERIFIED; HEPATIC STELLATE CELLS; HEPATOCYTES; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER; LIVER CIRRHOSIS; MATRIX METALLOPROTEINASE 2; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 84922753298     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2014.12.006     Document Type: Article

References (38)

1. Adams L.A., Lymp J.F., St Sauver J., Sanderson S.O., Lindor K.D., Feldstein A., Angulo P. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005, 129:113-121.
2. Benyon R.C., Iredale J.P., Goddard S., Winwood P.J., Arthur M.J. Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver. Gastroenterology 1996, 110:821-831.
3. Bhatia S.N., Balis U.J., Yarmush M.L., Toner M. Effect of cell-cell interactions in preservation of cellular phenotype: cocultivation of hepatocytes and nonparenchymal cells. FASEB J. 1999, 13:1883-1900.
4. Bissell D.M., Roulot D., George J. Transforming growth factor beta and the liver. Hepatology 2001, 34:859-867. 10.1053/jhep.2001.28457.
5. Borkham-Kamphorst E., Kovalenko E., van Roeyen C.R.C., Gassler N., Bomble M., Ostendorf T., Floege J., Gressner A.M., Weiskirchen R. Platelet-derived growth factor isoform expression in carbon tetrachloride-induced chronic liver injury. Lab. Investig. 2008, 88:1090-1100. 10.1038/labinvest.2008.71.
6. Canbay A., Taimr P., Torok N., Higuchi H., Friedman S., Gores G.J. Apoptotic body engulfment by a human stellate cell line is profibrogenic. Lab. Investig. 2003, 83:655-663.
7. Chavez-Tapia N.C., Rosso N., Tiribelli C. In vitro models for the study of non-alcoholic fatty liver disease. Curr. Med. Chem. 2011, 18:1079-1084.
8. Chavez-Tapia N.C., Rosso N., Tiribelli C. Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease. BMC Gastroenterol. 2012, 12:20. 10.1186/1471-230X-12-20.
9. Chávez-Tapia N.C., Rosso N., Uribe M., Bojalil R., Tiribelli C. Kinetics of the inflammatory response induced by free fatty acid accumulation in hepatocytes. Ann. Hepatol. 2013, 13:113-120.
10. Fontana L., Jerez D., Rojas-Valencia L., Solís-Herruzo J.A., Greenwel P., Rojkind M. Ethanol induces the expression of alpha 1(I) procollagen mRNA in a co-culture system containing a liver stellate cell-line and freshly isolated hepatocytes. Biochim. Biophys. Acta 1997, 1362:135-144.
11. Friedman S.L. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol. Rev. 2008, 88:125-172. 10.1152/physrev.00013.2007.
12. Giraudi P.J., Bellarosa C., Coda-Zabetta C.D., Peruzzo P., Tiribelli C. Functional induction of the cystine-glutamate exchanger system Xc(-) activity in SH-SY5Y cells by unconjugated bilirubin. PLoS One 2011, 6:e29078. 10.1371/journal.pone.0029078.
13. Gómez-Lechón M.J., Donato M.T., Castell J.V., Jover R. Human hepatocytes in primary culture: the choice to investigate drug metabolism in man. Curr. Drug Metab. 2004, 5:443-462.
14. Gressner O.A., Gressner A.M. Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases. Liver Int. 2008, 28:1065-1079. 10.1111/j.1478-3231.2008.01826.x.
15. Gry M., Rimini R., Strömberg S., Asplund A., Pontén F., Uhlén M., Nilsson P. Correlations between RNA and protein expression profiles in 23 human cell lines. BMC Genomics 2009, 10:365. 10.1186/1471-2164-10-365.
16. Hemmann S., Graf J., Roderfeld M., Roeb E. Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies. J. Hepatol. 2007, 46:955-975. 10.1016/j.jhep.2007.02.003.
17. Herron G.S., Werb Z., Dwyer K., Banda M.J. Secretion of metalloproteinases by stimulated capillary endothelial cells. I. Production of procollagenase and prostromelysin exceeds expression of proteolytic activity. J. Biol. Chem. 1986, 261:2810-2813.
18. Iredale J.P., Benyon R.C., Arthur M.J., Ferris W.F., Alcolado R., Winwood P.J., Clark N., Murphy G. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology 1996, 24:176-184. 10.1002/hep.510240129.
19. Janorkar A.V., Harris L.M., Murphey B.S., Sowell B.L. Use of three-dimensional spheroids of hepatocyte-derived reporter cells to study the effects of intracellular fat accumulation and subsequent cytokine exposure. Biotechnol. Bioeng. 2011, 108:1171-1180. 10.1002/bit.23025.
20. Kaminska B., Wesolowska A., Danilkiewicz M. TGF beta signalling and its role in tumour pathogenesis. Acta Biochim. Pol. 2005, 52:329-337.
21. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., Ferrell L.D., Liu Y.-C., Torbenson M.S., Unalp-Arida A., Yeh M., McCullough A.J., Sanyal A.J., Nonalcoholic Steatohepatitis Clinical Research Network Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41:1313-1321. 10.1002/hep.20701.
22. Krause P., Saghatolislam F., Koenig S., Unthan-Fechner K., Probst I. Maintaining hepatocyte differentiation in vitro through co-culture with hepatic stellate cells. In Vitro Cell. Dev. Biol. Anim. 2009, 45:205-212. 10.1007/s11626-008-9166-1.
23. Mezaki Y., Morii M., Hebiguchi T., Yoshikawa K., Yamaguchi N., Miura M., Imai K., Yoshino H., Senoo H. Differential increases in the expression of intermediate filament proteins and concomitant morphological changes of transdifferentiating rat hepatic stellate cells observed in vitro. Acta Histochem. Cytochem. 2013, 46:137-143. 10.1267/ahc.13007.
24. Mukherji S., Ebert M.S., Zheng G.X.Y., Tsang J.S., Sharp P.A., van Oudenaarden A. MicroRNAs can generate thresholds in target gene expression. Nat. Genet. 2011, 43:854-859. 10.1038/ng.905.
25. Nieto N., Cederbaum A.I. Increased Sp1-dependent transactivation of the LAMgamma 1 promoter in hepatic stellate cells co-cultured with HepG2 cells overexpressing cytochrome P450 2E1. J. Biol. Chem. 2003, 278:15360-15372. 10.1074/jbc.M206790200.
26. Nieto N., Friedman S.L., Cederbaum A.I. Cytochrome P450 2E1-derived reactive oxygen species mediate paracrine stimulation of collagen I protein synthesis by hepatic stellate cells. J. Biol. Chem. 2002, 277:9853-9864. 10.1074/jbc.M110506200.
27. Pinzani M., Gesualdo L., Sabbah G.M., Abboud H.E. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J. Clin. Invest. 1989, 84:1786-1793. 10.1172/JCI114363.
28. Reeves H.L., Burt A.D., Wood S., Day C.P. Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis. J. Hepatol. 1996, 25:677-683.
29. Rius B., Titos E., Morán-Salvador E., López-Vicario C., García-Alonso V., González-Périz A., Arroyo V., Clària J. Resolvin D1 primes the resolution process initiated by calorie restriction in obesity-induced steatohepatitis. FASEB J. 2014, 28:836-848. 10.1096/fj.13-235614.
30. Rojkind M., Novikoff P.M., Greenwel P., Rubin J., Rojas-Valencia L., de Carvalho A.C., Stockert R., Spray D., Hertzberg E.L., Wolkoff A.W. Characterization and functional studies on rat liver fat-storing cell line and freshly isolated hepatocyte coculture system. Am. J. Pathol. 1995, 146:1508-1520.
31. Stefanovic B., Hellerbrand C., Brenner D.A. Regulatory role of the conserved stem-loop structure at the 5' end of collagen alpha1(I) mRNA. Mol. Cell. Biol. 1999, 19:4334-4342.
32. Strutz F., Okada H., Lo C.W., Danoff T., Carone R.L., Tomaszewski J.E., Neilson E.G. Identification and characterization of a fibroblast marker: FSP1. J. Cell Biol. 1995, 130:393-405.
33. Thomas R.J., Bhandari R., Barrett D.A., Bennett A.J., Fry J.R., Powe D., Thomson B.J., Shakesheff K.M. The effect of three-dimensional co-culture of hepatocytes and hepatic stellate cells on key hepatocyte functions in vitro. Cells Tissues Organs 2005, 181:67-79. 10.1159/000091096.
34. Tsukada S., Parsons C.J., Rippe R.A. Mechanisms of liver fibrosis. Clin. Chim. Acta 2006, 364:33-60. 10.1016/j.cca.2005.06.014.
35. Tullberg-Reinert H., Jundt G. In situ measurement of collagen synthesis by human bone cells with a Sirius Red-based colorimetric microassay: effects of transforming growth factor beta2 and ascorbic acid 2-phosphate. Histochem. Cell Biol. 1999, 112:271-276.
36. Wang Z., Lv J., Zhang R., Zhu Y., Zhu D., Sun Y., Zhu J., Han X. Co-culture with fat cells induces cellular insulin resistance in primary hepatocytes. Biochem. Biophys. Res. Commun. 2006, 345:976-983. 10.1016/j.bbrc.2006.04.173.
37. Wong V.W.-S. Nonalcoholic fatty liver disease in Asia: a story of growth. J. Gastroenterol. Hepatol. 2013, 28:18-23. 10.1111/jgh.12011.
38. Xu L., Hui A.Y., Albanis E., Arthur M.J., O'Byrne S.M., Blaner W.S., Mukherjee P., Friedman S.L., Eng F.J. Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut 2005, 54:142-151. 10.1136/gut.2004.042127.